TrialCardiovascular drugs and therapy2022

Quality of Life Assessment in Trials of Revascularization for Chronic Stable Angina: Insights from ORBITA and the Implications of Blinding.

Alexandra N Nowbar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.